Zai Lab Limited (ZLAB)

Nasdaq: ZLAB · Pharmaceutical Preparations · Shanghai · filing with the SEC since 2017

Grade6.0

◀ Past 7.1● Present 6.2▶ Future 4.6

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 26, 2026	Feb 27, 2025	Feb 27, 2024	Mar 1, 2023	Mar 1, 2022	Mar 1, 2021	Apr 29, 2020	Mar 29, 2019	Apr 30, 2018	·
Revenue	457,182,000	397,614,000	266,719,000	212,672,000	144,105,000	48,958,000	12,985,000	129,000^r	·	·
Cost of revenue	190,520,000	147,118,000	95,816,000	74,018,000	52,239,000	16,736,000	3,749,000	43,000^r	·	·
Gross profit	·	·	·	·	·	·	·	85,862	·	·
Research and development	220,904,000	234,504,000	265,868,000	286,408,000	573,306,000	222,711,000	142,221,000	120,278,000^r	39,342,000^r	32,149,157
Selling, general and administrative	277,605,000	298,741,000	281,608,000	258,971,000	218,831,000	111,312,000	70,211,000	21,576,000^r	12,049,000^r	6,380,144
General and administrative	·	·	·	·	·	·	·	·	12,049,518	6,380,144
Operating income	-229,434,000	-282,117,000	-366,573,000	-404,357,000	-700,064,000	-301,801,000	-203,196,000	-141,768,000^r	-51,391,000^r	-38,529,301
Interest expense	5,209,000	2,254,000	0	0	0	181,000	293,000	40,000^r	·	·
Interest and investment income	33,048,000	37,105,000	39,797,000	14,582,000	2,190,000	5,120,000	8,232,000	3,261,000^r	527,000^r	403,266
Share of profit of equity-method investments	·	0	0	-221,000	-1,057,000	-1,119,000	-752,000	-587,000^r	-249,652	·
Other income (expense), net	3,540,000	5,300,000	7,006,000	3,113,000	-10,201,000^r	7,417,000^r	938,000	59,000	530,000	·
Income before income taxes	-178,464,000	-257,103,000	-334,620,000	-443,286,000	-704,471,000	-268,905,000	-195,071,000	-139,075,000^r	-50,384,000^r	-37,512,212
Income tax expense	-2,927,000	0	0	0	0	0	0	0	0	·
Net income	-175,537,000	-257,103,000	-334,620,000	-443,286,000	-704,471,000	-268,905,000	-195,071,000	-139,075,000^r	-50,384,000^r	-37,512,212
Net income to common shareholders	-175,537,000	-257,103,000	-334,620,000	-443,286,000	-704,471,000	-268,905,000	-195,071,000	-139,075,000^r	-50,384,000^r	-37,512,212
Earnings per share, basic	-0.16	-0.26	-0.35	-0.46	-0.76	-0.35	·	·	·	·
Earnings per share, diluted	-0.16	-0.26	-0.35	-0.46	-0.76	-0.35	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-7.58	-3.46	-3.03	-2.64	-2.32	-3.97
Weighted average shares, basic	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·	·	·	·
Weighted average shares, diluted	1,095,311,090	989,477,730	966,394,130	958,067,140	929,921,120	776,677,430	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	92,992,112	77,667,743	64,369,490	52,609,810	21,752,757	9,439,028

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton ZLAB · research, not advice